Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • lorendarith
    • Jul 2026

    Mapping to related species

    How much mismatch is enough and not too much?

    If I want to map my reads to related genera/species (within a family) how much mismatch should I allow. Obviously, if I set no or very little mismatches I will find conserved regions among them.

    The question is - how to inspect how much their genomes are similar by just mapping reads? Should I just stick to stringent criteria and just go the way -> the more similar they are, the more reads will map even with no or little mismatches?

    I will do whole genome alignments, but until I get a good assembly I thought I could try it this way. No?

    Thanks!
  • severin
    Genome Informatics Facility
    • Sep 2009
    • 105

    #2
    which species?

    The other important question is whether there has been a lot of whole genome duplication or a lot of paralogues in the genes you are interested in looking at.
    Many plants have a lot of more "recent" whole genome duplications than animals for instance.

    You could always use a loose constraint say 30% mismatch and see what aligns. You could also plot the number of reads given a certain level of mismatch. You can filter the alignments after they are aligned based on whatever cutoff makes the most sense.

    Comment

    • lorendarith

      #3
      ATM I'm not really interested in any particular genes, but am doing this in order to get more insight on the relatedness to other species with sequenced genomes.

      The problem is that the genus of the species I'm working on has no distinct placement in the family tree of e.g. Brassicaceae. Based on phylogenies with different markers, the closest related species with a sequenced genome also differs from publication to publication.

      I guess what I really want to achieve with this is to preform some sort of synteny mapping without large pesudomolecules.

      Comment

      • MicroBio
        Member
        • Dec 2012
        • 15

        #4
        Going off of what severin was saying, do you think you could use a loose mapping constraint to pick out some regions of interest (areas where your reads map to other species), and then perform a PhastCons type of analysis to see how much conservation there is in that region between your genome of interest and those with related sequences? This way you would pick up weakly matching regions (because of the loose mapping constraint) that would show low conservation between genomes, and high matching regions with higher conservation scores.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...